AnorMED expectation

Related by string. * AnorMed . Anormed : PRNewswire FirstCall AnorMED . AnorMED / expecta tions . EXPECTATIONS . EXPECTATION . expectations . Expectations . expec tations . Expectation : THOSE BELIEFS PLANS EXPECTATIONS . goals expectations anticipations . objectives expectations anticipations . expectations anticipations estimates . lofty expectations . wildest expectations * *

Related by context. Frequent words. (Click for all words.) 59 Eligard R 58 Phase IIa clinical trials 56 MOZOBIL 56 Nasdaq VRTX 56 elotuzumab 55 NEBIDO 55 BLA submission 55 FDA approvable letter 55 NASDAQ BPAX 55 Phenoptin 55 liquidating distributions 54 liprotamase 54 talactoferrin 54 Biotie 54 Repurchase Program 54 Visudyne R 53 Complete Response letter 53 Solzira 53 IoGen 53 velaglucerase alfa 53 TOCOSOL Paclitaxel 53 BEMA Buprenorphine 53 REPLAGAL 53 Allovectin 7 R 53 BrachySil 52 Amended Agreement 52 Sandstorm Resources 52 Plenaxis R 52 SILENOR TM 52 confirmatory Phase III 52 Retisert 52 ATryn ® 52 MONOVISC 52 Onsolis 52 Cellegy 52 Poly ICR 52 Laquinimod 52 QTDP 52 ATL# [001] 52 ELND# 52 Novexel 52 vernakalant iv 52 Protox 51 Omigard 51 Dynogen 51 Orphan Drug designation 51 orphan designation 51 Zerenex 51 ATryn R 51 Furiex 51 BioDelivery Sciences 51 elagolix 51 Sensipar 51 Investigational Device Exemption 51 orBec R 51 NovaDel 51 Asentar 51 Addrenex 51 ZALBIN 51 deforolimus 51 Trizytek 51 Private Placement Offering 51 Icatibant 51 requisite regulatory approvals 51 Corautus 51 voclosporin 50 Convertible Loan 50 ONSOLIS 50 Paladin Labs 50 Orphan Drug Status 50 AnorMED 50 THELIN 50 EPIX Pharmaceuticals 50 KRYSTEXXA 50 Clevudine 50 Stock Repurchase Plan 50 Belinostat 50 BioMarin Genzyme LLC 50 CEFF 50 valopicitabine 50 Combination Agreement 50 CCX# 50 alvimopan 50 Cannasat 50 convertible promissory notes 50 underwriters overallotment option 50 Ausam 50 MacroChem 50 apaziquone 50 FIRAZYR 49 TheCompany 49 PREOS 49 Humanitarian Device Exemption 49 vernakalant oral 49 Term Loan Facility 49 oral calcitonin 49 BEMA Fentanyl 49 confirmatory Phase 3 49 Share Repurchase Plan 49 Investigational Device Exemption IDE 49 Proposed Qualifying Transaction

Back to home page